Clinical Trials Directory

Trials / Unknown

UnknownNCT03127046

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Dong Wha Pharmaceutical Co. Ltd. · Industry
Sex
Male
Age
19 Years
Healthy volunteers
Accepted

Summary

To evaluate the drug-drug interaction between aceclofena and esomeprazole

Detailed description

A randomized, open-label, single dose, 3-way crossover study to evaluate the drug-drug interaction between Aceclofenac 200 mg and Esomeprazole 20 mg in healthy male volunteers

Conditions

Interventions

TypeNameDescription
DRUGAceclofenacOral single dose administration of aceclofenac 200mg
DRUGEsomeprazoleOral single dose administration of aceclofenac 200mg
DRUGAceclofenac and EsomeprazoleOral single dose administration of aceclofenac 200mg and esomeprazole concomitant

Timeline

Start date
2017-03-31
Primary completion
2017-04-16
Completion
2017-04-23
First posted
2017-04-25
Last updated
2017-04-25

Locations

1 site across 1 country: South Korea

Regulatory

Source: ClinicalTrials.gov record NCT03127046. Inclusion in this directory is not an endorsement.